Emergency Contraceptive Pills Market Synopsis

The Global Emergency Contraceptive Pills Market size is expected to grow from USD 1.02 billion in 2022 to USD 1.20 billion by 2030, at a CAGR of 2.1% during the forecast period (2023-2030).

Emergency contraception may be a method of preventing pregnancy following unprotected sex. Emergency contraceptive pills (ECPs), also referred to as the contraceptive, are pills that must be taken before 120 hours (5 days) after having unprotected sex.

  • The Emergency Contraceptive Pills (ECP) market has witnessed significant growth and evolution, driven by increasing awareness about contraception and reproductive health. These pills, also known as morning-after pills, are designed to prevent unintended pregnancies when taken shortly after unprotected intercourse. The market has expanded globally, with rising demand fuelled by factors such as increasing sexual education, changing societal attitudes towards family planning, and improved accessibility to healthcare.
  • Key players in the pharmaceutical industry have introduced innovative formulations and improved distribution channels, contributing to the market's growth. Governments and non-profit organizations have also played a crucial role in promoting the use of emergency contraceptives through awareness campaigns and initiatives. The market has seen advancements in both prescription and over-the-counter (OTC) options, providing consumers with a range of choices.

Emergency Contraceptive Pills Market Trend Analysis

Increase In The Number Of Unplanned Pregnancies

  • The surge in unplanned pregnancies has become a pivotal driving force behind the remarkable growth of the Emergency Contraceptive Pills (ECP) market. In contemporary society, factors such as inadequate contraceptive usage, contraceptive failure, and lack of awareness contribute to an escalating number of unintended pregnancies. Emergency Contraceptive Pills serve as a crucial solution in mitigating the consequences of unprotected intercourse and offer a viable option for women to prevent unplanned pregnancies.
  • The increasing awareness about emergency contraception, coupled with changing societal norms and greater emphasis on reproductive health, has propelled the demand for these pills. Moreover, the accessibility and availability of emergency contraceptive pills have expanded, contributing to their widespread adoption. The rising incidence of unprotected sexual encounters, driven by various societal factors, underscores the need for effective and accessible emergency contraception options. Emergency Contraceptive Pills Market is witnessing substantial growth, addressing a pressing public health concern while empowering individuals to make informed choices about their reproductive health.

The Rising Adoption Rate Of Emergency Contraceptive Pills creates an Opportunity

  • The escalating adoption of emergency contraceptive pills (ECPs) presents a significant growth opportunity for the Emergency Contraceptive Pills Market. As societal awareness regarding reproductive health and family planning continues to expand, the demand for accessible and effective contraceptive options, particularly in emergency situations, is on the rise.
  • Factors such as changing lifestyles, increased awareness through education, and evolving cultural norms contribute to the growing acceptance and utilization of emergency contraceptive pills. The convenience and availability of these pills over-the-counter further enhance their accessibility, empowering individuals to take control of their reproductive choices.
  • Moreover, the increasing prevalence of unprotected sexual encounters and the need for timely intervention to prevent unintended pregnancies fuel the demand for emergency contraceptive solutions. Pharmaceutical companies and healthcare providers are strategically positioned to capitalize on this trend by developing innovative formulations, investing in marketing strategies, and expanding distribution channels.

Emergency Contraceptive Pills Market Segment Analysis:

Emergency Contraceptive Pills Market Segmented on the basis of Product Type, Distribution Channel.

By Product Type, combination pill segment is expected to dominate the market during the forecast period

  • The dominance of the combination pill segment can be attributed to several factors. The convenience of a single pill containing both hormones simplifies the administration process, enhancing user compliance. The high effectiveness of combination pills contributes to their popularity among healthcare providers and consumers alike. Additionally, the versatility of combination pills in addressing various aspects of the reproductive process makes them a preferred choice for emergency contraception.
  • Moreover, the combination pill's well-established safety profile and relatively lower side effects further contribute to its prominence in the market. As awareness about emergency contraception continues to grow, the combination pill segment is expected to maintain its leading position, fostering market growth and meeting the evolving needs of individuals seeking reliable and accessible contraceptive solutions.

By Distribution Channel, E-Commerce segment held the largest share of xx% in 2022

  • The dominance of E-Commerce in the Emergency Contraceptive Pills market can be attributed to several factors. Firstly, the online platform ensures the privacy and confidentiality that individuals often seek when purchasing such sensitive products. Additionally, the ease of comparing products, reading reviews, and obtaining detailed information online contributes to informed decision-making.
  • Furthermore, the increasing penetration of internet services and the growing trend of digitalization in healthcare have fueled the adoption of E-Commerce for pharmaceuticals, including emergency contraceptives. This shift in consumer behavior, coupled with the convenience offered by online purchasing, positions the E-Commerce segment as a key player in the Emergency Contraceptive Pills market, driving its anticipated dominance in the distribution channels. As the market continues to evolve, E-Commerce is expected to play a pivotal role in meeting the demands of consumers for accessible and confidential healthcare solutions.

Emergency Contraceptive Pills Market Regional Insights:

Asia Pacific is Expected to Dominate the Market Over the Forecast period

  • The Asia Pacific region is poised to take a leading position in the global Emergency Contraceptive Pills (ECP) market, showcasing significant growth and dominance. This trend is attributed to various factors that underscore the region's increasing awareness about reproductive health, changing socio-cultural dynamics, and the rising demand for family planning options.
  • Key drivers contributing to the dominance of the Asia Pacific in the ECP market include the implementation of educational programs, government initiatives promoting family planning, and the expanding accessibility of healthcare services. Moreover, the region's large population, particularly in countries like China and India, amplifies the demand for emergency contraceptive solutions, further propelling market growth.
  • Additionally, the evolving healthcare infrastructure, coupled with a surge in disposable income in many Asia Pacific countries, enhances the affordability and accessibility of emergency contraceptive pills. This confluence of factors positions the Asia Pacific region as a key player in the global market for emergency contraceptive pills, with expectations of sustained growth and a leading market share in the foreseeable future.

Emergency Contraceptive Pills Market Top Key Players:

  • Bayer AG (Germany)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • HRL Laboratories, LLC (USA)
  • Cipla Limited (India)
  • Gedeon Richter Plc. (Hungary)
  • Actavis Group PTC (Iceland)
  • Laboratorios Andrómaco S.A. (Chile)
  • Zhejiang Medicine Group Co., Ltd. (China)
  • Laboratorio SIDI S.A. (Argentina)
  • Hsieh's Holdings Limited (Hong Kong)
  • Aspen Pharmacare Holdings Ltd. (South Africa)
  • Wallace Pharmaceuticals Pty Ltd. (Australia)
  • Wincon Medical Group Co., Ltd. (China)
  • Shandong Lukang Pharmaceutical Group Co., Ltd. (China)
  • Zhengzhou Pharmaceutical Factory Co., Ltd. (China)
  • Chongqing Tianxin Pharmaceutical Co., Ltd. (China)
  • Wuhan Huafei Pharmaceuticals Co., Ltd. (China)
  • Xi'an Zhongmei Pharmaceutical Co., Ltd. (China)
  • Jiangxi Kanbon Pharmaceutical Co., Ltd. (China)
  • Chongqing Jialin Pharmaceutical Co., Ltd. (China)

Key Industry Developments in the Emergency Contraceptive Pills Market:

  • In July 2023, Teva Pharmaceuticals acquired Anda Pharmaceuticals for $575 million. This acquisition strengthens Teva's position in the women's health market, giving them access to Anda's popular EC pill, NextChoice One-Step.
  • In September 2023, private equity firm Advent International acquired a significant stake in HRA Pharma, the manufacturer of Ella, an emergency contraceptive pill known for its longer window of effectiveness. This investment aims to accelerate HRA Pharma's global expansion and product development.

Global Emergency Contraceptive Pills Market

Base Year:

2022

Forecast Period:

2023-2030

Historical Data:

2017 to 2022

Market Size in 2022:

USD 1.02 Bn.

Forecast Period 2023-30 CAGR:

2.1%

Market Size in 2030:

USD 1.20 Bn.

Segments Covered:

By Product Type

  • Progesterone Pills
  • Estrogen Pills
  • Combination Pills

By Distribution Channel

  • Pharmacies
  • E-Commerce
  • Healthcare Facilities

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

Increase In The Number Of Unplanned Pregnancies

Key Market Restraints:

Side-Effects Related To The Emergency Contraceptive Pills

Key Opportunities:

The Rising Adoption Rate Of Emergency Contraceptive Pills

Companies Covered in the report:

  • Teva Pharmaceutical Industries Ltd. (Israel), Bayer AG (Germany), HRA Pharma (France), Piramal Enterprises Limited (India), Mankind Pharma Ltd. (India), and Other major players.
  1. INTRODUCTION
    1. RESEARCH OBJECTIVES
    2. RESEARCH METHODOLOGY
    3. RESEARCH PROCESS
    4. SCOPE AND COVERAGE
      1. Market Definition
      2. Key Questions Answered
    5. MARKET SEGMENTATION
  2. EXECUTIVE SUMMARY
  3. MARKET OVERVIEW
  4. GROWTH OPPORTUNITIES BY SEGMENT
  5. MARKET LANDSCAPE
    1. PORTER’S FIVE FORCES ANALYSIS
      1. Bargaining Power Of Supplier
      2. Threat Of New Entrants
      3. Threat Of Substitutes
      4. Competitive Rivalry
      5. Bargaining Power Among Buyers
    2. INDUSTRY VALUE CHAIN ANALYSIS
    3. MARKET DYNAMICS
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
    4. MARKET TREND ANALYSIS
    5. REGULATORY LANDSCAPE
    6. PESTLE ANALYSIS
    7. PRICE TREND ANALYSIS
    8. PATENT ANALYSIS
    9. TECHNOLOGY EVALUATION
    10. MARKET IMPACT OF THE RUSSIA-UKRAINE WAR
      1. Geopolitical Market Disruptions
      2. Supply Chain Disruptions
      3. Instability in Emerging Markets
    11. ECOSYSTEM
  6. EMERGENCY CONTRACEPTIVE PILLS MARKET BY PRODUCT TYPE (2016-2030)
    1. EMERGENCY CONTRACEPTIVE PILLS MARKET SNAPSHOT AND GROWTH ENGINE
    2. MARKET OVERVIEW
    3. PROGESTERONE PILLS
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2016 – 2030F)
      3. Historic And Forecasted Market Size in Volume (2016 – 2030F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
    4. ESTROGEN PILLS
    5. COMBINATION PILLS
  7. EMERGENCY CONTRACEPTIVE PILLS MARKET BY DISTRIBUTION CHANNEL (2016-2030)
    1. EMERGENCY CONTRACEPTIVE PILLS MARKET SNAPSHOT AND GROWTH ENGINE
    2. MARKET OVERVIEW
    3. PHARMACIES
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2016 – 2030F)
      3. Historic And Forecasted Market Size in Volume (2016 – 2030F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
    4. E-COMMERCE
    5. HEALTHCARE FACILITIES
  8. COMPANY PROFILES AND COMPETITIVE ANALYSIS
    1. COMPETITIVE LANDSCAPE
      1. Competitive Positioning
      2. EMERGENCY CONTRACEPTIVE PILLS Market Share By Manufacturer (2022)
      3. Industry BCG Matrix
      4. Heat Map Analysis
      5. Mergers & Acquisitions
    2. BAYER AG (GERMANY)
      1. Company Overview
      2. Key Executives
      3. Company Snapshot
      4. Role of the Company in the Market
      5. Sustainability and Social Responsibility
      6. Operating Business Segments
      7. Product Portfolio
      8. Business Performance (Production Volume, Sales Volume, Sales Margin, Production Capacity, Capacity Utilization Rate)
      9. Key Strategic Moves And Recent Developments
      10. SWOT Analysis
    3. TEVA PHARMACEUTICAL INDUSTRIES LTD. (ISRAEL)
    4. HRL LABORATORIES, LLC (USA)
    5. CIPLA LIMITED (INDIA)
    6. GEDEON RICHTER PLC. (HUNGARY)
    7. ACTAVIS GROUP PTC (ICELAND)
    8. LABORATORIOS ANDRÓMACO S.A. (CHILE)
    9. ZHEJIANG MEDICINE GROUP CO., LTD. (CHINA)
    10. LABORATORIO SIDI S.A. (ARGENTINA)
    11. HSIEH'S HOLDINGS LIMITED (HONG KONG)
    12. ASPEN PHARMACARE HOLDINGS LTD. (SOUTH AFRICA)
    13. WALLACE PHARMACEUTICALS PTY LTD. (AUSTRALIA)
    14. WINCON MEDICAL GROUP CO., LTD. (CHINA)
    15. SHANDONG LUKANG PHARMACEUTICAL GROUP CO., LTD. (CHINA)
    16. ZHENGZHOU PHARMACEUTICAL FACTORY CO., LTD. (CHINA)
    17. CHONGQING TIANXIN PHARMACEUTICAL CO., LTD. (CHINA)
    18. WUHAN HUAFEI PHARMACEUTICALS CO., LTD. (CHINA)
    19. XI'AN ZHONGMEI PHARMACEUTICAL CO., LTD. (CHINA)
    20. JIANGXI KANBON PHARMACEUTICAL CO., LTD. (CHINA)
    21. CHONGQING JIALIN PHARMACEUTICAL CO., LTD. (CHINA)
  9. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET BY REGION
    1. OVERVIEW
    2. NORTH AMERICA
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Product Type
      4. Historic And Forecasted Market Size By Distribution Channel
      5. Historic And Forecasted Market Size By Country
        1. USA
        2. Canada
        3. Mexico
    3. EASTERN EUROPE
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
        1. Russia
        2. Bulgaria
        3. The Czech Republic
        4. Hungary
        5. Poland
        6. Romania
        7. Rest Of Eastern Europe
    4. WESTERN EUROPE
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
        1. Germany
        2. United Kingdom
        3. France
        4. The Netherlands
        5. Italy
        6. Spain
        7. Rest Of Western Europe
    5. ASIA PACIFIC
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Malaysia
        6. Thailand
        7. Vietnam
        8. The Philippines
        9. Australia
        10. New-Zealand
        11. Rest Of APAC
    6. MIDDLE EAST & AFRICA
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
        1. Turkey
        2. Bahrain
        3. Kuwait
        4. Saudi Arabia
        5. Qatar
        6. UAE
        7. Israel
        8. South Africa
    7. SOUTH AMERICA
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
  10. INVESTMENT ANALYSIS
  11. ANALYST VIEWPOINT AND CONCLUSION
    1. Recommendations and Concluding Analysis
    2. Potential Market Strategies

 

Global Emergency Contraceptive Pills Market

Base Year:

2022

Forecast Period:

2023-2030

Historical Data:

2017 to 2022

Market Size in 2022:

USD 1.02 Bn.

Forecast Period 2023-30 CAGR:

2.1%

Market Size in 2030:

USD 1.20 Bn.

Segments Covered:

By Product Type

  • Progesterone Pills
  • Estrogen Pills
  • Combination Pills

By Distribution Channel

  • Pharmacies
  • E-Commerce
  • Healthcare Facilities

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

Increase In The Number Of Unplanned Pregnancies

Key Market Restraints:

Side-Effects Related To The Emergency Contraceptive Pills

Key Opportunities:

The Rising Adoption Rate Of Emergency Contraceptive Pills

Companies Covered in the report:

  • Teva Pharmaceutical Industries Ltd. (Israel), Bayer AG (Germany), HRA Pharma (France), Piramal Enterprises Limited (India), Mankind Pharma Ltd. (India), and Other major players.

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. EMERGENCY CONTRACEPTIVE PILLS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. EMERGENCY CONTRACEPTIVE PILLS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. EMERGENCY CONTRACEPTIVE PILLS MARKET COMPETITIVE RIVALRY
TABLE 005. EMERGENCY CONTRACEPTIVE PILLS MARKET THREAT OF NEW ENTRANTS
TABLE 006. EMERGENCY CONTRACEPTIVE PILLS MARKET THREAT OF SUBSTITUTES
TABLE 007. EMERGENCY CONTRACEPTIVE PILLS MARKET BY PRODUCT TYPE
TABLE 008. PROGESTERONE PILLS MARKET OVERVIEW (2016-2028)
TABLE 009. ESTROGEN PILLS MARKET OVERVIEW (2016-2028)
TABLE 010. COMBINATION PILLS MARKET OVERVIEW (2016-2028)
TABLE 011. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 012. EMERGENCY CONTRACEPTIVE PILLS MARKET BY DISTRIBUTION CHANNEL
TABLE 013. ONLINE MARKET OVERVIEW (2016-2028)
TABLE 014. OFFLINE MARKET OVERVIEW (2016-2028)
TABLE 015. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 016. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 017. N EMERGENCY CONTRACEPTIVE PILLS MARKET, BY COUNTRY (2016-2028)
TABLE 018. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 019. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 020. EMERGENCY CONTRACEPTIVE PILLS MARKET, BY COUNTRY (2016-2028)
TABLE 021. ASIA PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 022. ASIA PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 023. EMERGENCY CONTRACEPTIVE PILLS MARKET, BY COUNTRY (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 025. MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 026. EMERGENCY CONTRACEPTIVE PILLS MARKET, BY COUNTRY (2016-2028)
TABLE 027. SOUTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 028. SOUTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 029. EMERGENCY CONTRACEPTIVE PILLS MARKET, BY COUNTRY (2016-2028)
TABLE 030. TEVA PHARMACEUTICAL INDUSTRIES LTD.: SNAPSHOT
TABLE 031. TEVA PHARMACEUTICAL INDUSTRIES LTD.: BUSINESS PERFORMANCE
TABLE 032. TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCT PORTFOLIO
TABLE 033. TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 033. BAYER AG: SNAPSHOT
TABLE 034. BAYER AG: BUSINESS PERFORMANCE
TABLE 035. BAYER AG: PRODUCT PORTFOLIO
TABLE 036. BAYER AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 036. HRA PHARMA: SNAPSHOT
TABLE 037. HRA PHARMA: BUSINESS PERFORMANCE
TABLE 038. HRA PHARMA: PRODUCT PORTFOLIO
TABLE 039. HRA PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 039. PIRAMAL ENTERPRISES LIMITED: SNAPSHOT
TABLE 040. PIRAMAL ENTERPRISES LIMITED: BUSINESS PERFORMANCE
TABLE 041. PIRAMAL ENTERPRISES LIMITED: PRODUCT PORTFOLIO
TABLE 042. PIRAMAL ENTERPRISES LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 042. MANKIND PHARMA LTD.: SNAPSHOT
TABLE 043. MANKIND PHARMA LTD.: BUSINESS PERFORMANCE
TABLE 044. MANKIND PHARMA LTD.: PRODUCT PORTFOLIO
TABLE 045. MANKIND PHARMA LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. RICHTER GEDEON NYRT: SNAPSHOT
TABLE 046. RICHTER GEDEON NYRT: BUSINESS PERFORMANCE
TABLE 047. RICHTER GEDEON NYRT: PRODUCT PORTFOLIO
TABLE 048. RICHTER GEDEON NYRT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. LUPIN LIMITED: SNAPSHOT
TABLE 049. LUPIN LIMITED: BUSINESS PERFORMANCE
TABLE 050. LUPIN LIMITED: PRODUCT PORTFOLIO
TABLE 051. LUPIN LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. COOPER PHARMA: SNAPSHOT
TABLE 052. COOPER PHARMA: BUSINESS PERFORMANCE
TABLE 053. COOPER PHARMA: PRODUCT PORTFOLIO
TABLE 054. COOPER PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. PFIZER INC.: SNAPSHOT
TABLE 055. PFIZER INC.: BUSINESS PERFORMANCE
TABLE 056. PFIZER INC.: PRODUCT PORTFOLIO
TABLE 057. PFIZER INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. ZHEJIANG XIANJU PHARMACEUTICAL CO.: SNAPSHOT
TABLE 058. ZHEJIANG XIANJU PHARMACEUTICAL CO.: BUSINESS PERFORMANCE
TABLE 059. ZHEJIANG XIANJU PHARMACEUTICAL CO.: PRODUCT PORTFOLIO
TABLE 060. ZHEJIANG XIANJU PHARMACEUTICAL CO.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 061. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 062. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 063. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. EMERGENCY CONTRACEPTIVE PILLS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. EMERGENCY CONTRACEPTIVE PILLS MARKET OVERVIEW BY PRODUCT TYPE
FIGURE 012. PROGESTERONE PILLS MARKET OVERVIEW (2016-2028)
FIGURE 013. ESTROGEN PILLS MARKET OVERVIEW (2016-2028)
FIGURE 014. COMBINATION PILLS MARKET OVERVIEW (2016-2028)
FIGURE 015. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 016. EMERGENCY CONTRACEPTIVE PILLS MARKET OVERVIEW BY DISTRIBUTION CHANNEL
FIGURE 017. ONLINE MARKET OVERVIEW (2016-2028)
FIGURE 018. OFFLINE MARKET OVERVIEW (2016-2028)
FIGURE 019. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. ASIA PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. SOUTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET OVERVIEW BY COUNTRY (2016-2028)

Please Wait...

Frequently Asked Questions :

What would be the forecast period in the Emergency Contraceptive Pills Market research report?

The forecast period in the Emergency Contraceptive Pills Market research report is 2023-2030.

Who are the key players in the Emergency Contraceptive Pills Market?

Bayer AG (Germany), Teva Pharmaceutical Industries Ltd. (Israel), HRL Laboratories, LLC (USA), Cipla Limited (India), Gedeon Richter Plc. (Hungary), Actavis Group PTC (Iceland), Laboratorios Andrómaco S.A. (Chile), Zhejiang Medicine Group Co., Ltd. (China), Laboratorio SIDI S.A. (Argentina), Hsieh's Holdings Limited (Hong Kong), Aspen Pharmacare Holdings Ltd. (South Africa), Wallace Pharmaceuticals Pty Ltd. (Australia), Wincon Medical Group Co., Ltd. (China), Shandong Lukang Pharmaceutical Group Co., Ltd. (China), Zhengzhou Pharmaceutical Factory Co., Ltd. (China), Chongqing Tianxin Pharmaceutical Co., Ltd. (China), Wuhan Huafei Pharmaceuticals Co., Ltd. (China), Xi'an Zhongmei Pharmaceutical Co., Ltd. (China), Jiangxi Kanbon Pharmaceutical Co., Ltd. (China), Chongqing Jialin Pharmaceutical Co., Ltd. (China) and Other Major Players.

What are the segments of the Emergency Contraceptive Pills Market?

The Emergency Contraceptive Pills Market is segmented into Product Type, Distribution Channel, and region. By Product Type, the market is categorized into Progesterone Pills, Estrogen Pills, Combination Pills, and Others. By Distribution Channel, the market is categorized into Pharmacies, E-commerce, Healthcare Facilities. By region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Russia; Spain; Rest of Western Europe), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).

What is the Emergency Contraceptive Pills Market?

Emergency contraception may be a method of preventing pregnancy following unprotected sex. Emergency contraceptive pills (ECPs), also referred to as the contraceptive, are pills that must be taken before 120 hours (5 days) after having unprotected sex

How big is the Emergency Contraceptive Pills Market?

The Global Emergency Contraceptive Pills Market size is expected to grow from USD 1.02 billion in 2022 to USD 1.20 billion by 2030, at a CAGR of 2.1% during the forecast period (2023-2030).